Soft tissue sarcomas of adults: state of the translational science.
Ernest C. Borden(Cleveland Clinic), Murray F. Brennan(Memorial Sloan Kettering Cancer Center), Paul S. Meltzer(National Cancer Institute), Robert S. Bell, Brian O’Sullivan(University of Toronto), David Parkinson(Korea Astronomy and Space Science Institute), Marc Ladanyi(Memorial Sloan Kettering Cancer Center), Christopher D.�M. Fletcher(Brigham and Women's Hospital), George D. Demetri(Dana-Farber Cancer Institute), Murali Sundaram(University of Cincinnati), Sharon W. Weiss(Tel Aviv University), Laurence H. Baker(Memorial Sloan Kettering Cancer Center), Burton Eisenberg(Hoag Memorial Hospital Presbyterian), Jill Waalen(University of California San Diego), Jaap Verweij(Deutz (Germany)), Jonathan A. Fletcher(Harvard University), Allan T. van Oosterom(Cleveland Clinic), Peter W. T. Pisters(The University of Texas MD Anderson Cancer Center), Vivien Bramwell(Western University), Samuel Singer(Memorial Sloan Kettering Cancer Center), Scott Saxman(Eastern Cooperative Oncology Group)
PubMed
June 1, 2003
Cited by 616
Related Papers
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
|New England Journal of Medicine|2002|4.4k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k